Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Maraviroc
Medication labelMaraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency…
Why this: Advisory · dailymed-prescription
Maraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg. Limitations of Use: • Maraviroc tablets are not recommended in patients with dual/mixed- or CXCR4-tropic HIV-1 [see Microbiology ( 12.4)].
- generic_name
- maraviroc
- product_names
- Maraviroc
- ndc
- 72865-231, 72865-232, 72865-231-60, 72865-232-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en